secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2025-04-11T23:59:59+00:00
Accession:  0001641172-25-003880
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics receives Nasdaq delisting notice for bid price below $1; plans reverse stock split
--------------------------------------------------------------------------------

- Received Nasdaq deficiency letter on April 7, 2025 for failing minimum bid price of $1 per share for 30 consecutive business days.
- Has 180-day compliance period until October 6, 2025 to regain compliance by closing bid price >= $1 for 10 consecutive business days.
- Intends to seek stockholder approval for a reverse stock split at upcoming annual meeting to increase share price.
- No immediate effect on listing; if not compliant, Nasdaq may delist, subject to appeal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000164117225003880/0001641172-25-003880-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000164117225003880/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-003880

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer